Uremic Toxins of Patients With Acute Kidney Failure

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00148044

Enrollment

Registered

2005-09-07

Start date

2003-10-31

Completion date

2004-02-29

Last updated

2007-12-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney Failure, Acute

Brief summary

Determination of the concentration of uremic toxins of sepsis patients with or without acute kidney failure compared to the concentrations of uremic toxins of chronically uremic patients

Detailed description

Determination of the concentration of uremic toxins of sepsis patients with or without acute kidney failure compared to the concentrations of uremic toxins of chronically uremic patients

Interventions

PROCEDUREBlood sampling for determination of uremic toxins

Study design

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Intensive Care patients with sepsis * Patients with acute kidney failure: serum creatinin \> 2 mg/dl * Chronic haemodialysis patients

Exclusion criteria

* \< 18 years

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026